Ιατρικά Άρθρα: Immunotherapy in Head and Neck Squamous Cell Carcinoma : Phase 2 Trial Evaluating the Efficacy and the Toxicity of Nivolumab Alone, and of the Combination Nivolumab and Ipilimumab

Τρίτη 23 Ιανουαρίου 2018

Immunotherapy in Head and Neck Squamous Cell Carcinoma : Phase 2 Trial Evaluating the Efficacy and the Toxicity of Nivolumab Alone, and of the Combination Nivolumab and Ipilimumab

Condition: Head and Neck Squamous Cell Carcinoma
Interventions: Drug: Nivolumab; Drug: Ipilimumab
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
Not yet recruiting

http://ift.tt/2G9t4iM

Ιατρικά Άρθρα

Ετικέτες

Τρίτη 23 Ιανουαρίου 2018

Immunotherapy in Head and Neck Squamous Cell Carcinoma : Phase 2 Trial Evaluating the Efficacy and the Toxicity of Nivolumab Alone, and of the Combination Nivolumab and Ipilimumab

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Multifunctional Two-Dimensional Bi<sub>2</sub>Se<sub>3</sub> Nanodiscs for Anti-Inflammatory Therapy of Inflammatory Bowel Diseases

Αναζήτηση αυτού του ιστολογίου

Αναφορά κατάχρησης